There were 76 press releases posted in the last 24 hours and 164,705 in the last 365 days.

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market to Rise Impressively at 9.5% CAGR; Recent Regulatory Approvals to Provide Impetus, says Fortune Business Insights

Key companies covered in the Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Research report include Merck & Co., Inc., Pfizer Inc., MELINTA THERAPEUTICS, INC., ALLERGAN, Paratek Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. among others.

/EIN News/ -- Pune, July 29, 2019 (GLOBE NEWSWIRE) -- The global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market will derive growth from the increasing usage approvals in recent years. According to a report published by Fortune Business Insights, titledAcute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,270.9 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 14,972.6 Mn by the end of 2026, thereby exhibiting a CAGR of 9.5%.

Recent developments in acute bacterial skin and skin structure infections (ABSSSI) treatment methods such as the advent of novel drugs and therapies will favor growth of the global market. The report stresses on the latest industry development and signifies the impact of these developments on the Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market value. The report includes segmentation of the market based on several factors such as infection type, route of administration, distribution channel, and regional demographics.


Browse Complete Report Details with Table of Content and Figures:
https://www.fortunebusinessinsights.com/industry-reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market-100971


Besides these, the report provides insights into a few of the factors that have constituted for the increase in the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market value. The increasing prevalence of acute bacterial skin and skin structure infections (ABSSSI) around the world has led to increasing demand for acute bacterial skin and skin structure infections (ABSSSI) treatment options across the world. On account of the aforementioned factors, companies are looking to generate Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market revenue.

Omadacycline’s FDA Approval to Benefit Market Growth

The increasing demand for acute bacterial skin and skin structure infections (ABSSSI) treatment options is encouraging healthcare manufacturers to come up with newer therapies and recombinant drugs. In the wake of such high demand, regulatory authorities have eased off their reluctance on approving drugs with minimal side effects. Increasing regulatory approvals will have a positive impact on the global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market. In 2018, the Food and Drug Administration passed approval for the usage of omadacycline in the treatment of patients diagnosed with acute bacterial skin and skin structure infections (ABSSSI). The ability of omadacycline to act in various drug delivery methods such as oral and intravenous form will lead to a rising uptake among end users globally. Fortune Business Insights has predicted that the approval for omadacycline will have a positive impact on the global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market in the forthcoming years.

Merck & Co., Inc and Pfizer Inc. Contribute Significantly Towards Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Revenue

Increasing mergers and acquisitions (M&As) are favoring growth of the market in recent years. The report provides a detailed analysis of key mergers and acquisitions in the market and signifies their impact on the global market. Merck & Co., one of the leading companies, has till date, completed acquisition of several companies that are engaged in the research and development of drugs and therapies for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Pfizer Inc., is another company that has adopted exceptional business strategies that have directly made a significant impact on the growth of the global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market. Fortune Business Insights has predicted together, Merck & Co. and Pfizer will account for the maximum market share during the forecast period.


Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market-100971


Fortune Business Insights has profiled some of the leading Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market companies and signified their impact on the global market.

The report analysis comprises of market dynamics and competitive landscape. Additionally, the report offers insights on the prevalence of bacterial skin infections in key countries, new product launch, pipeline analysis, and recent industry developments such as mergers & acquisitions. 

Market Players Covered

  • Merck & Co., Inc.
  • Pfizer Inc.
  • MELINTA THERAPEUTICS, INC.
  • ALLERGAN
  • Paratek Pharmaceuticals, Inc.
  • Cumberland Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Other prominent players


Speak to Analyst  https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market-100971

Table of Content:

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities

  • Key Insights
    • Prevalence of Bacterial Skin Infections- By key countries,2018
    • New Product Launch
    • Pipeline Analysis
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018

  • Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Infection Type
      • Hospital-acquired ABSSSI
      • Community-acquired ABSSSI
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Parenteral
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • Competitive Analysis
  • Strategic Recommendations


Request for Customization:    https://www.fortunebusinessinsights.com/enquiry/customization/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market-100971


Browse Related Reports:

  • Advanced Wound Care Market Size, Share and Global Trend by Product (Advanced Wound Dressings, Wound Care Devices & Active Wound Care), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Others), End User and Geography Forecast till 2025

  • Advanced Wound Dressings Market Size, Share and Global Trend by Product Type (Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025

  • Active Wound Care Market Size, Share and Global Trend by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), End User (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025

  • Wound Care Devices Market Size, Share and Global Trend by Product Type (Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), Extracorporeal Shock Wave Therapy (ESWT)), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025


About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact us:
Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com 
Website: https://www.fortunebusinessinsights.com

Attachment

Primary Logo

Merck & Co., Inc andPfizer Inc., to Account for Maximum Market Share in Terms of Revenue

Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Share and Global Trends


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.